
X
Standing on the cusp of something great: How real-world data is poised to transform cancer care
https://pharmaphorum.com/whitepapers/standing-cusp-something-great-real-world-data-poised-transform-cancer-care/
With time running out on Brexit, companies are already making long-term decisions.
Though they can reduce the costs of health care, biosimilars still face challenges to access.
New survey reveals the huge task facing pharma in keeping medicines moving around Europe after Brexit.
Taking stock of one PRIME, of the EMA’s flagship market access initiatives.
The aims and implications of the Health Service Medical Supplies (Costs) Act 2017.